BDTX-1535 Size:10mg

BDTX-1535 Size:10mgDescription BDTX 1535 is an orally bioavailable, brain penetrating, mutation selective, EGFR inhibitor with potential antitumor activity. BDTX 1535 is a fourth generation EGFR inhibitor that overcomes resistance to Osimertinib, the standard of care for EGFR mutant nonsmall cell lung cancer (NSCLC). BDTX 1535 works well in NSCLC carrying C797S. Importantly, BDTX 1535 can cross the blood brain barrier and potentially treat CNS metastases in NSCLC. BDTX

13 g/mol and a density of 1

◆ Liquid nitrogen pump is optional

biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color

What types of applications are T75 tissue culture flasks commonly used for

2 18901377 VT2

Synonyms: AGEs

It combines both magnetic stirrer and titrator functions

The product is suitable for most cell lines and stem cells and has excellent performance in primary cell culture

5 18900024 VT2

Specifications OS20-S Max

50/60Hz Power 40W Dimension[D×W×H] 220×510×260mm Permissible ambient temperature and humidity 5-40°C

Binding Capacity